By promoting VEGF (vascular endothelial growth factor) expression and modulating the nitric oxide system, BPC-157 restores blood supply to damaged tissue, which accelerates the healing cascade
Capsules may offer minor benefit, especially for gut health, but they have very low bioavailability and lack clinical support
Researchers often study how cells communicate during repair and renewal processes, and GHK-CU is frequently included in these investigations
This study reveals a key mechanism by which BPC-157 may help with healing and tissue repair by improving blood supply
The only retrospective human study included 12 patients who received intra-articular BPC-157 for chronic knee pain, of whom 7 reported symptom improvement lasting more than 6 months
Researchers have explored BPC-157 in studies involving: Cellular signaling pathways Molecular biology research Cytoskeletal organization Nitric oxide pathway signaling Extracellular matrix regulation Growth-factor communication networks Gastrointestinal biology models Tissue biology investigations Peptide stability investigations Rather than binding to a single isolated receptor, preclinical literature indicates that BPC-157 influences a cascade of molecular communication networks: VEGFR2 Activation and Angiogenesis: In vitro models demonstrate that BPC-157 upregulates the expression of Vascular Endothelial Growth Factor A (VEGF-A) and triggers the phosphorylation of Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) (Hsieh et al., 2017)